A total 35 percent of healthcare professionals worldwide believe that digital transformation — involving the use of technologies such as artificial intelligence (AI), big data, cloud computing, application programming interfaces (API) and digital platforms — would improve both pre-clinical and clinical trials, according to a survey by GlobalData. GlobalData also noted that drug developers that had not considered virtual trials will have no option but to rapidly invest in this technology if they want to stay competitive.
